コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 cups of coffee/day, or the third quintile of caffeine consumption).
2 more detailed study of the health effects of caffeine consumption.
3 nonsmokers who had moderate alcohol or heavy caffeine consumption.
4 ified in this population with relatively low caffeine consumption.
5 characterize GxE in the specific context of caffeine consumption.
6 Mean birth weight was reduced by reported caffeine consumption (-28 g per 100 mg of caffeine consu
8 s may underlie associations between maternal caffeine consumption and adverse childhood metabolic out
9 examining the associations between momentary caffeine consumption and affective states in naturalisti
13 rst prenatal visit and were questioned about caffeine consumption and important confounding factors.
17 evaluate the associations between coffee and caffeine consumption and various health outcomes, we per
19 2 sessions were acquired without controlled caffeine consumption, and 2 sessions after oral ingestio
20 We observed that T2D, as well as higher BMI, caffeine consumption, and tobacco use, were associated w
22 vels of plasma caffeine, but lower levels of caffeine consumption, as individuals with these variants
27 reductions were apparent even with levels of caffeine consumption below clinically recommended guidel
30 dependent, the public health consequences of caffeine consumption cannot be determined without data o
32 and STS and negatively with CS, and frequent caffeine consumption correlated positively with burnout
34 Therefore, our data suggest that elevated caffeine consumption does not contribute to the increasi
35 esic effects of acupuncture, and controlling caffeine consumption during acupuncture may improve pain
39 a-analysis examining the association between caffeine consumption during pregnancy and risk of preter
43 lity in this cohort-smoking, alcohol intake, caffeine consumption, exercise, body mass index, and his
45 individuals with these variants require less caffeine consumption for the same physiological effect.
46 h abnormalities with complete information on caffeine consumption from 12 US clinical sites between 2
49 However, the impact of genetic factors on caffeine consumption, heavy use, intoxication, tolerance
50 s been reported in association with smoking, caffeine consumption, higher serum urate concentrations,
52 eine intake in children, recent estimates of caffeine consumption in a representative sample of child
56 echanisms associated with habitual (chronic) caffeine consumption in the mouse hippocampus using unta
60 rease in birth weight, observed for maternal caffeine consumption, is unlikely to be clinically impor
63 erval of 6.1 years, 44 patients with various caffeine consumption levels underwent clinical and imagi
64 cal studies have reported that coffee and/or caffeine consumption may reduce Alzheimer's disease (AD)
67 nt of caffeine consumption demonstrated that caffeine consumption, particularly from regular coffee,
68 x (BMI), type 2 diabetes (T2D), tobacco use, caffeine consumption, pesticide exposure, head injury, a
71 nimal studies have converged to suggest that caffeine consumption prevents memory deficits in aging a
72 1) and a positive association was found with caffeine consumption (R2beta*, 0.003; 95% CI, 0.000-0.00
73 027; 95% CI, 0.020-0.034; P < .001) and less caffeine consumption (R2beta*, 0.013; 95% CI, 0.009-0.01
74 studies, we investigated whether coffee and caffeine consumption reduced the risk of elevated alanin
76 d cisplatin for ototoxicity and suggest that caffeine consumption should be cautioned in cancer patie
77 ght gain in participants who increased their caffeine consumption than in those who decreased their c
79 use a food-frequency instrument for dietary caffeine consumption to evaluate the relationship betwee
81 , we examined the relationship of coffee and caffeine consumption to the risk of this disease among p
82 articipants whose cumulatively updated total caffeine consumption was <125 mg/day, participants who c
84 on of caffeinated coffee as compared with no caffeine consumption was associated with 154 and 102 dai
85 st (>=232 mg/day) versus lowest (<87 mg/day) caffeine consumption was associated with a 0.10-mmHg low
86 est ( 232 mg/day) versus lowest (<87 mg/day) caffeine consumption was associated with a 0.10-mmHg low
87 andomization failed to provide evidence that caffeine consumption was associated with arrhythmias.
88 etic predisposition to elevated IOP, greater caffeine consumption was associated with higher IOP and
89 inated coffee, total coffee, tea, or overall caffeine consumption was associated with the risk of RA,
92 % confidence interval 0.14-0.66).Those whose caffeine consumption was heavy also had a doubled risk f
93 association was also evident in those whose caffeine consumption was heavy who did not smoke (adjust
94 cohort of initially healthy women, elevated caffeine consumption was not associated with an increase
95 m paraxanthine concentration, which reflects caffeine consumption, was associated with a higher risk
99 Epidemiological studies have strongly linked caffeine consumption with a reduced risk of developing P
100 is consistent with an inverse association of caffeine consumption with development of PD based on pas
101 weight (mg/kg) to examine the association of caffeine consumption with sociodemographic factors and d